Amphia Ziekenhuis
Breda, Netherlands
Treatment & access
- Treatments offeredesketamine (Spravato)
- Access routepublic_reimbursed
- Price informationReimbursed via Dutch basic health insurance (esketamine nasal spray for TRD)
- ReimbursementMember of Esketamine Neusspray Consortium (ENC-NL); esketamine covered per ENC-NL protocol How reimbursement works in Europe →
- Websitehttps://www.amphia.nl/folders/psychiatrie-esketamine-neusspray
About this provider
Amphia hospital in Breda offers esketamine nasal spray for severe depression when other treatments have proven insufficient, documented in the psychiatry department's patient folder. Patients administer the spray themselves in the presence of a nurse and then remain in hospital for at least two hours under close nursing observation. During treatment, blood pressure, temperature, pulse and oxygen saturation are measured regularly, and questionnaires are completed before and after each session to track effect and side effects. Patients attend fasting (three hours before treatment); side effects typically begin within minutes of administration, decrease within an hour and are generally gone after two hours.
Services & programs
- Esketamine nasal spray treatment at the hospital psychiatry department
- Nurse-supervised self-administration with at least two hours of monitored observation per session
- Vital-signs monitoring during treatment: blood pressure, temperature, pulse and oxygen saturation
- Questionnaire-based monitoring before and after treatment sessions
Common questions
What happens during a treatment session?
You spray the esketamine into your nose yourself in the presence of a nurse. Afterwards you stay in the hospital for at least two hours while a nurse keeps a close eye on you; your blood pressure, temperature, pulse and oxygen saturation are measured regularly, and questionnaires are completed around the session.
How should I prepare?
You must attend fasting: no food for three hours before the treatment.
What about side effects?
Side effects usually start within minutes after administration, decrease within one hour and are generally gone after two hours, which is why you remain under observation. Amphia's folder also warns that esketamine nasal spray can occasionally cause serious allergic symptoms (anaphylaxis) such as breathing problems, skin swelling and rash.
Verification
- License / registryENC-NL
- Sourcehttps://enc-nl.nl/
- Last verified